Published 5 July 2005. doi:10.1084/jem.20050566
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 1, 5-10
Dendritic cells star in Vancouver
Eynav Klechevskya,b,c,
Hiroki Katoa,b,c, and
Anne-Marit Sponaasa,b,c
a E.K. is at Baylor Institute for Immunology Research, Dallas, TX 75204 and the Technion Israel Institute of Technology, Haifa 32000, Israel.
b H.K. is at Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
c A.-M.S. is at Parasitology Division, National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA, UK.
CORRESPONDENCE E.K.: eynavk{at}baylorhealth.edu OR H.K.: hiroki{at}biken.osaka-u.ac.jp OR A-M.S: sponaas{at}nimr.mrc.ac.uk
Abstract
The fast-moving field of dendritic cell (DC) biology is hard to keep pace with. Here we report on advances from the recent Keystone Symposium, "Dendritic Cells at the Center of Innate and Adaptive Immunity," organized in Vancouver, BC on Feb. 17, 2005 by Anne O'Garra, Jacques Banchereau, and Alan Sher. New insights into the molecular mechanisms of DC function and their influence on immune regulation, their role in infectious and autoimmune disease, and new clinical applications are highlighted.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Lesimple, T., Neidhard, E.-M., Vignard, V., Lefeuvre, C., Adamski, H., Labarriere, N., Carsin, A., Monnier, D., Collet, B., Clapisson, G., Birebent, B., Philip, I., Toujas, L., Chokri, M., Quillien, V.
(2006). Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients. Clin. Cancer Res.
12: 7380-7388
[Abstract]
[Full Text]